Hironobu Minami
Division of Oncology
National Cancer Center Hospital East
Kashiwa
Japan
Name/email consistency: high
- Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28. Minami, H., Sai, K., Saeki, M., Saito, Y., Ozawa, S., Suzuki, K., Kaniwa, N., Sawada, J., Hamaguchi, T., Yamamoto, N., Shirao, K., Yamada, Y., Ohmatsu, H., Kubota, K., Yoshida, T., Ohtsu, A., Saijo, N. Pharmacogenet. Genomics (2007)
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients. Minami, H., Kawada, K., Sasaki, Y., Igarashi, T., Saeki, T., Tahara, M., Itoh, K., Fujii, H. Cancer Sci. (2006)
- Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?. Minami, H., Ohe, Y., Niho, S., Goto, K., Ohmatsu, H., Kubota, K., Kakinuma, R., Nishiwaki, Y., Nokihara, H., Sekine, I., Saijo, N., Hanada, K., Ogata, H. J. Clin. Oncol. (2004)
- Phase I study of intravenous PSC-833 and doxorubicin: reversal of multidrug resistance. Minami, H., Ohtsu, T., Fujii, H., Igarashi, T., Itoh, K., Uchiyama-Kokubu, N., Aizawa, T., Watanabe, T., Uda, Y., Tanigawara, Y., Sasaki, Y. Jpn. J. Cancer Res. (2001)
- Pharmacodynamic modeling of the entire time course of leukopenia after a 3-hour infusion of paclitaxel. Minami, H., Sasaki, Y., Watanabe, T., Ogawa, M. Jpn. J. Cancer Res. (2001)
- Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks. Minami, H., Fujii, H., Igarashi, T., Itoh, K., Tamanoi, K., Oguma, T., Sasaki, Y. Clin. Cancer Res. (2001)
- Indirect-response model for the time course of leukopenia with anticancer drugs. Minami, H., Sasaki, Y., Saijo, N., Ohtsu, T., Fujii, H., Igarashi, T., Itoh, K. Clin. Pharmacol. Ther. (1998)